TickerFactsScreenerDevelopers

ImmunityBio, Inc. (IBRX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2013: -$3.75M2014: $57.59M2015: $356.00M2016: $293.42M2017: $218.84M2018: $146.01M2019: $120.68M2020: -$119.81M2021: -$242.17M2022: -$447.33M2023: -$586.99M2024: -$489.10M2025: -$500.47M-$500.47M
2013Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$500.47M-2.3%
2024-$489.10M+16.7%
2023-$586.99M-31.2%
2022-$447.33M-84.7%
2021-$242.17M-102.1%
2020-$119.81M-199.3%
2019$120.68M-17.3%
2018$146.01M-33.3%
2017$218.84M-25.4%
2016$293.42M-17.6%
2015$356.00M+518.1%
2014$57.59M+1633.7%
2013-$3.75M—